Blood Plasma Derivatives Market Professional Survey Report 2017

Global Blood Plasma Derivatives Information by type (Albumin, Anti-Thrombin III, Intravenous immunoglobulin (IVIG), Fresh Frozen Plasma (FFP) and others), by application (Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others), by end users (Hospitals, clinics, diagnostic centers, blood transfusion centers and others- Forecast to 2023

Market Research Future Publish a New Report on – “Blood Plasma Derivatives Market Research Report- Forecast To 2023”

Exclusive Summery About Report:

Blood plasma derivatives have a wide range of applications thus increasing their demand in the market. They are used in various diseases like HIV, hepatitis B and Hepatitis C. Plasma derivatives are collected from large number of donors for their use in patients suffering from life threatening diseases. Hence the importance of blood plasma derivatives has increased in healthcare. The global market of Blood Plasma Derivatives is expected to reach US$ 58.2 billion in 2023 from US$ 30.5 billion in 2016 with a CAGR of approximately 7.52% during the forecast period 2017-2023.

Increasing incidences of thrombocytosis and related complication is a major driver for the growth of blood plasma market throughout the globe. Center for Disease Control (CDC) and the National Institutes of Health (NIH) conducts awareness programs for prevented thrombocytosis.

Test the market data and market information presented through more than 45 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Blood Plasma Derivatives market Research Report –Global Forecast to 2023.”

Blood Plasma Derivatives Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

  • Grifols (Germany),
  • SK Plasma (Korea),
  • Fusion Healthcare (India),
  • Baxter International Inc. (U.S),
  • CSL Limited (Australia).
  • Octapharma AG (Germany),
  • Biotest AG (Germany),
  • Bain Capital (U.S).

Request a Sample Report @



Global Blood Plasma Derivatives market has been segmented on the basis of type whichincludes albumin, anti-thrombin, intravenous immunoglobulin (IVIG), fresh frozen plasma (FFP) and others. Others types are Factor VII, Factor IX and Alpha 1 proteinase inhibitor concentrate. On the basis on application the market is segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease. End users include hospitals, clinics, diagnostic centers, blood transfusion centers and others.

Regional Analysis of Blood Plasma Derivatives Market:

Globally, Blood Plasma Derivatives market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa.  North America is the largest market for syringe and needle. The North American market for Blood Plasma Derivatives is expected to grow at a CAGR of 4.25% which is expected to reach at US$ 35.50 billion from US$ 20 billion in 2016 by the end of the forecasted period. Awareness regarding use of plasma derivatives for patients suffering from infectious diseases drive this market in North America. Europe is the second-largest market for Blood Plasma Derivatives which is expected to grow at a CAGR of 3.8%. Extensive research on safe blood transfusion in healthcare organizations and research laboratories favor the growth of this market in Europe. Whereas Asia Pacific is expected to be the fastest growing market for Blood Plasma Derivatives market. India is expected to be the emerging and fastest growing market. Demand for plasma derivatives for inactivation of HIV favor the demand of plasma derivatives in Asia-pacific. The market shows steady growth in Middle East and Africa.

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @  

Intended Audience

  • Blood Plasma Derivatives Companies
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Diagnostic centers
  • Blood transfusion centers
  • Academic Medical Institutes and Universities

Table of Content

1        Report Prologue   

2         Market Introduction   

2.1      Introduction   

2.2      Scope of Study   

2.3      Research Objective   

2.4       Assumptions & Limitations   

2.4.1    Assumptions   

2.4.2    Limitations   

3           Research Methodology   

3.1        Research Process   

3.2        Primary Research   

3.3        Secondary Research   

4           Market Dynamics   

4.1      Drivers   

4.1.1    Increasing incidences of infectious diseases   

4.1.2    Increasing awareness use of blood plasma derivatives in HIV

4.2      Restraints   

4.2.1    Safety concerns during blood transfusion

5           Market Factor Analysis   


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Akash Anand,

Market Research Future

+1 646 845 9312




Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India